The administration of lithium alleviated the impairment of memory and emotion in the DGKβ KO mice [198], which suggested that the expression level of DGKβ is a putative biomarker for screening patients with lithium-responsive bipolar disorder. Here, DGKB is linked to bipolar disorder.